Official UK procurement notice
Aseptically Prepared Dosebanded Medicines 2022
Authority: HealthTrust Europe LLP (HTE) Acting On Behalf of University Hospital Coventry and Warwickshire (Education)·Consortium: 2 public authorities
What is being bought29 lots · detail below
Published requirement descriptionThe Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
CPV: Medical solutions · Pharmaceutical articles · Pharmaceutical products · Pharmacy services
How this framework works
From the published notice- Bids received
- 3 bids received · 4 suppliers appointed
Lots and requirements (29)Procurement structure
25 of 29 loaded on this pageShowing the first 25 of 29 published lots; the full list is in the JSON and Markdown mirrors of this notice. 29 lots · 24 with a published value · same evaluation weights on every lot.
Every one of these 21 lots carries the same published figure, £100,000,000: it is the framework's maximum for the whole notice, not each lot's own budget, and no share per lot is published. The cards below say ceiling above rather than repeat it.
Lot #1HTE established a framework agreement for the supply of a range of aseptically…Lot estimate not published
HTE established a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti cancer chemotherapy drugs in ready to administer presentations and agreed dose bands. The framework agreement covers the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses are based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
Lot #2Aseptically Prepared Dose Banded MedicinesCancelledRenewalPublished value£500,000,000
Lot #3CIVAS (Centralised Intravenous Additive Service)CancelledRenewalPublished value£200,000,000
Lot #4Patient Specific ChemotherapyCancelledRenewalPublished value£300,000,000
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe’s discretion.
Lot #5BORTEZOMIBCancelledRenewalceiling above
Lot #6EPIRUBICINCancelledRenewalceiling above
Lot #7FLUOROURACILCancelledRenewalceiling above
Lot #8GANCICLOVIRCancelledRenewalceiling above
Lot #9GEMCITABINECancelledRenewalceiling above
Lot #10INFLIXIMABCancelledRenewalceiling above
Lot #11IRINOTECANCancelledRenewalceiling above
Lot #12METHOTREXATECancelledRenewalceiling above
Lot #13NIVOLUMABCancelledRenewalceiling above
Lot #14OXALIPLATINCancelledRenewalceiling above
Lot #15PACLITAXELCancelledRenewalceiling above
Lot #16CARBOPLATINCancelledRenewalceiling above
Lot #17PEMBROLIZUMABCancelledRenewalceiling above
Lot #18PERTUZUMABCancelledRenewalceiling above
Lot #19RITUXIMABCancelledRenewalceiling above
Lot #20TRASTUZUMAB SCCancelledRenewalceiling above
Lot #21TRASTUZUMAB IVCancelledRenewalceiling above
Lot #22VINCRISTINECancelledRenewalceiling above
Lot #23CETUXIMABCancelledRenewalceiling above
Lot #24CISPLATINCancelledRenewalceiling above
Lot #25CYCLOPHOSPHAMIDECancelledRenewalceiling above
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- Price carries 40 of 100 points: a 10% discount moves about 4 points. The method statement decides this lot, not the discount.
- “Aseptically Prepared Dosebanded Medicines 2022” is a framework: the contest is a place on its panel, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 7 Jan 2022, 22:45 GMT
- Last source update
- 30 Jul 2026, 07:17 BST
- Award evaluation window
- 14 Feb 2022 – …
- FTS notice number
2026/S 000-071947- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0308cdFind a Tender
Publisher note: TERMS AND CONDITIONS / ACTIVITY BASED INCOME (ABI) The terms and conditions of this Framework Agreement is appended to the ITT. These terms include provisions requiring the payment by the supplier of an ABI management charge in consideration of the award of this Framework Agreement, the management and administration by HTE of the overall contract structure and associated documentation, as well as the requirement to submit regular management information to HTE. SUBMISSION OF EXPRESSIONS OF INTEREST AND PROCUREMENT INFORMATION. This exercise will be conducted on the HTE Bravo portal. Candidates wishing to be considered must register expressions of interest as follows: Register on the HTE portal at https://healthtrusteurope.bravosolution.co.uk. Login to the portal with username/password. Click the SQs/ITTs Open to All Suppliers link. These are the SQs/ITTs open to any registered supplier. Click on the relevant SQs/ITT to access the content. Click the Express Interest button at the top of the page. This will move the SQs/ITT into your My SQs/My ITTs page. You can access any attachments by clicking Buyer Attachments in the SQs/ITT Details box. Follow the onscreen instructions to complete the SQs/ITT. Submit your reply using the Submit Response button at the top of the page. If you require any further advice, contact the Bravo e-Tendering Help Desk at [email protected]. Sid4Gov HTE utilises the sid4gov supplier information database. Candidates should register on sid4gov at https://sid4gov.cabinetoffice.gov.uk/organisation/register and submit their sid4gov company profile for publication on the database. Candidates already registered on sid4gov must ensure information is up to date. Where access to sid4gov is unavailable, please contact the sid4gov helpdesk at [email protected]. Please note that sid4gov does not prepopulate any fields of the SQ on HTE's Bravo Portal. Candidates must complete the Qualfication & Technical envelopes of the SQ on Bravo in full.
How it was run
Official notice- Appointment period ends
- 14 Feb 2022, 12:00 GMT
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Supplier levy on call-offs (max %)
- document
- Bids opened
- 14 Feb 2022, 12:01 GMT
Timeline
14 Feb 2022 → 30 Jul 2026 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown14 Feb 2022, 12:00 GMT
- Bids opened14 Feb 2022, 12:01 GMT
- Notice published84 days ago30 Jul 2026, 07:17 BST
Notice history
2 events · 3 releases on Find a Tender · since 13 Jul 2022- Status changed to complete13 Jul 2022, 09:18 BST
- Buyer details updated30 Jul 2026, 07:17 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast4 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Aseptically Prepared Dosebanded Medicines 2022
- Signed
- 13 Jul 2022
- Value
- £3,500,000,000
- Status
- active
- Change The initial length of contract was 48 months. This modification is to extend the contract for an additional 7 months making it a total of 55 months. The value remains at £3500000000, Need for additional works, services or supplies by the original contractor/concessionaire: This modification is made in reliance on Regulation 72(1)(b) of the PCR 2015. It consists of a 7 months extension to the term of the existing framework. This extension is necessary to ensure continuity of supply and to avoid any interruption to services pending publication of the new Chemo Framework. The modification does not alter the overall nature of the framework, and the scope of services remains unchanged. Prices will remain fixed until 31st August 2026, new pricing will apply from 01st September 2026 which will remain fixed until 31st January 2027, after which there will be a change in value to reflect the new pricing structure that will be provided for in the new framework, however, this will not exceed 50% of the value of the original framework agreement.
Lot 3 – CIVAS (Centralised Intravenous Additive Service) – All Regions
- Signed
- 1 Jul 2022
- Value
- £200,000,000
- Status
- active
Lot 1- Aseptically Prepared Dose Banded Medicines Committed Spend - West Midlands Region
- Signed
- 1 Jul 2022
- Value
- £100,000,000
- Status
- active
Lot 2 - Aseptically Prepared Dose Banded Medicines – All Regions
- Signed
- 1 Jul 2022
- Value
- £500,000,000
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 2 · Aseptically Prepared Dose Banded Medicines | 4bids | — | — | — |
| 3 · CIVAS (Centralised Intravenous Additive Service) | 1bids | — | — | — |
| Whole notice | 3bids | — | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeConsortium members and other public bodies
- HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (“UHCW”)Contracting authorityBody governed by public lawHealth
Dispute resolution & review bodies
- Health Trust EuropeReview contact point
- HealthTrust Europe LLPReview body
- Legal DepartmentMediation bodyReview contact point
- Legal Department Health Trust EuropeMediation body
Framework contractors & participating bidders
9 commercial parties on the notice- BAXTER HEALTHCARE LIMITEDFramework contractor
- BAXTER HEALTHCARE LIMITEDFramework contractor
- Baxter Healthcare LimitedFramework contractor
- Healthcare at Home LtdFramework contractor
- Qualasept Ltd t/a Bath ASUFramework contractor
- Qualasept Ltd t/a Bath ASUFramework contractor
- Quantum PharmaceuticalFramework contractor
- Quantum Pharmaceutical LtdFramework contractor
- Sciensus Pharma Services LtdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.